Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00332579
Status:
COMPLETED
Last Update Posted:
2019-07-29
First Post:
2006-05-30
Brief Title:
Double-Blind Naltrexone in Kleptomania
Sponsor:
University of Minnesota
Organization:
University of Minnesota
Study Overview
Official Title:
A Double-Blind Placebo-Controlled Study of Naltrexone in Kleptomania
Status:
COMPLETED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in kleptomania
Detailed Description:
The proposed study will consist of 8 weeks of treatment with either naltrexone or placebo in 20 subjects with kleptomania The hypothesis to be tested is that naltrexone will be effective in reducing the urges to steal in patients with kleptomania The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None